Non-prescription proton-pump inhibitors for self-treating frequent heartburn: the role of the Canadian pharmacist

Non-prescription proton-pump inhibitors for self-treating frequent heartburn: the role of the Canadian pharmacist

Heartburn and acid regurgitation are the cardinal symptoms of gastroesophageal reflux and occur commonly in the Canadian population. Multiple non-prescription treatment options are available for managing these symptoms, including antacids, alginates, histamine-H2 receptor antagonists (H2RAs), and pr...

Full description

Bibliographic Details
Main Authors:	Armstrong D, Nakhla N
Format:	Article
Language:	English
Published:	Centro de Investigaciones y Publicaciones Farmaceuticas 2016-12-01
Series:	Pharmacy Practice
Subjects:	Community Pharmacy Services Professional Role Heartburn Gastroesophageal Reflux Proton Pump Inhibitors Self Care Canada
Online Access:	http://www.pharmacypractice.org/journal/index.php/pp/article/view/868/482

Similar Items

Current Trends in the Management of Gastroesophageal Reflux Disease
by: Dalbir S. Sandhu, et al.
Published: (2018-01-01)

Review of recent evidence on the management of heartburn in pregnant and breastfeeding women
by: Raja Affendi Raja Ali, et al.
Published: (2022-05-01)

Prevalence of non-obstructive dysphagia in patients with heartburn and regurgitation
by: Andrea Oliveira Batista, et al.
Published: (2020-01-01)

The importance of functional diagnostics in determining the cause of antisecretary therapy inefficiency in a patient with heartburn: clinical observation
by: E. V. Barkalova, et al.
Published: (2021-05-01)

Sleep disruption due to nocturnal heartburn: a review of the evidence and clinical implications
by: David A. Johnson, et al.
Published: (2023-12-01)

Functional heartburn: problems of diagnosis and treatment
by: Vadim A. Akhmedov, et al.
Published: (2024-03-01)

A child is worried about heartburn: modern views on the problem and possibilities of non-pharmacological support
by: O.Yu. Belousova, et al.
Published: (2024-06-01)

Complex Gastroesophageal Reflux Disease
by: Diana L. Snyder, et al.
Published: (2022-01-01)

Prevalence of heartburn and gastroesophageal reflux disease in the urban Brazilian population Prevalência da pirose e da doença gastroesofágica numa população urbana brasileira
by: Joaquim Prado P. Moraes-Filho, et al.
Published: (2005-06-01)

Redefining GERD management: The emerging role of potassium-competitive acid blockers
by: Vania Azalia Gunawan, et al.
Published: (2025-03-01)

Treatment of Heartburn: A Survey of Ontario and Québec Community Pharmacists
by: Nardine R. Nakhla, et al.
Published: (2024-05-01)

Features of the clinical course of gastroesophageal reflux disease associated with obesity
by: Andreeva E.l.
Published: (2018-03-01)

Gastroesophageal reflux disease, resistant to proton pump inhibitors
by: V. O. Kaybysheva, et al.
Published: (2011-06-01)

IMPACT OF HEARTBURN AND REGURGITATION ON INDIVIDUALS’ WELL-BEING IN THE GENERAL POPULATION: A BRAZILIAN NATIONAL SURVEY
by: Joaquim Prado P MORAES-FILHO, et al.

Sustained efficacy following resolution of frequent heartburn with an over-the-counter regimen of esomeprazole 20 mg or placebo for 14 days: two randomized trials
by: David A. Peura, et al.
Published: (2018-05-01)

Effect of Proton Pump Inhibitors in Bronchiectatic Patients with Gastroesophageal Reflux Disease
by: Byungkyu Ahn, et al.
Published: (2016-07-01)

Prevalencia y características de la enfermedad por reflujo gastroesofágico en mujeres embarazadas
by: Y-L.T. Le, et al.
Published: (2023-10-01)

The role of antacids in diseases related to excessive secretion of hydrochloric acid
by: Marcin Janiaczyk, et al.
Published: (2021-09-01)

The Frequency of Heartburn (GERD) and Its Related Factors in the Students of Hamadan University of Medical Sciences
by: Alireza Khalilian, et al.
Published: (2013-12-01)

Is empiric proton pump inhibition in patients with symptoms of extraesophageal gastroesophageal reflux justified?
by: Reidar Fossmark, et al.
Published: (2023-09-01)

Options for optimizing treatment of gastroesophageal reflux disease with proton pump inhibitors
by: M. F. Osipenko, et al.
Published: (2015-12-01)

Eosinophilic esophagitis in patients with typical gastroesophageal reflux disease symptoms refractory to proton pump inhibitor
by: Claudia Cristina de Sá, et al.
Published: (2011-01-01)

The Effect of Esomeprazole 40 mg Single Therapy in Patients with Non-Erosive Reflux Disease Who Are Resistant to Standard-Dose Proton Pump Inhibitor Therapy: An Open-Label Multicenter Study
by: Jae Kyu Sung, et al.
Published: (2016-12-01)

ESTIMATION OF CLINICAL AND PHARMACOECONOMIC EFFICIENCY OF PROTON PUMP INHIBITORS DURING GASTROESOPHAGEAL REFLUX DISEASE (GERD) TREATMENT
by: N. E. Shabanova, et al.
Published: (2018-12-01)

Proton pumps inhibitors in gastroesophageal reflux disease: what is the best regimen? A based evidence review
by: Rui JF Silva, et al.
Published: (2021-07-01)

Efficacy of the four weeks treatment of omeprazole plus mosapride combination therapy compared with that of omeprazole monotherapy in patients with proton pump inhibitor-refractory gastroesophageal reflux disease: a randomized controlled trial
by: Sirinawasatien A, et al.
Published: (2019-07-01)

Risk factors associated with gastroesophageal reflux disease relapse in primary care patients successfully treated with a proton pump inhibitor
by: A. López-Colombo, et al.
Published: (2017-04-01)

Meta-analysis of the efficacy of proton pump inhibitors for the symptoms of laryngopharyngeal reflux
by: C. Liu, et al.
Published: (2016-07-01)

Inadequate response to proton pump inhibitor therapy: Causes and patient management tactics
by: Iu V Evsiutina, et al.
Published: (2015-02-01)

Gastroesophageal reflux disease in a comorbid patient, refractory to proton pump inhibitors. How can we help?
by: I. G. Pakhomova
Published: (2024-11-01)

Proton pump inhibitors as treatment of laryngeal disorders among patients with gastroesophageal reflux disease: a single-arm (pre and post) quasi-experimental study
by: Mahmoud Ali Ragaee, et al.
Published: (2023-01-01)

The Impact of Direct-to-Consumer Pharmaceutical Advertising on Public Knowledge of Gastroesophageal Reflux Disease: A Study on Over-the-Counter Proton Pump Inhibitors
by: AlShammari M, et al.
Published: (2020-03-01)

Multicenter study of gastroesophageal reflux disease symptoms prevalence in outpatients in Russia
by: Dmitry S. Bordin, et al.
Published: (2022-01-01)

Comparison of clinical and pharmacodynamic features of proton pump inhibitors efficacy in gastroesophageal reflux disease
by: O. A. Storonova, et al.
Published: (2015-12-01)

Functional Changes of the Upper Esophageal Sphincter in Gastroesophageal Reflux
by: Roberto Oliveira Dantas
Published: (2022-10-01)

Heartburn Center Set-Up in a Community Setting: Engineering and Execution
by: Atul Maini, et al.
Published: (2021-11-01)

Proton pump inhibitors for the treatment of patients with erosive esophagitis and gastroesophageal reflux disease: current evidence and safety of dexlansoprazole
by: Mermelstein J, et al.
Published: (2016-07-01)

Pump Proton and Laryngeal H+/K+ ATPases
by: Zhang Z, et al.
Published: (2020-12-01)

Gastrointestinal symptoms associated with gastroesophageal reflux disease, and their relapses after treatment with proton pump inhibitors: A systematic review
by: Mousalreza Hosseini, et al.
Published: (2017-06-01)

New opinion on the issue of proton pump inhibitor-refractory gastroesophageal reflux disease
by: Yu. V. Yevsyutina, et al.
Published: (2014-11-01)